ICPT Annual EBIT
-$153.47 M
-$113.92 M-288.04%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual earnings before interest & taxes is -$153.47 million, with the most recent change of -$113.92 million (-288.04%) on December 31, 2022. During the last 3 years, it has risen by +$152.19 million (+49.79%).ICPT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly EBIT
-$1.21 M
+$2.17 M+64.22%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly earnings before interest & taxes is -$1.21 million, with the most recent change of +$2.17 million (+64.22%) on September 30, 2023. Over the past year, it has increased by +$98.28 million (+98.78%).ICPT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM EBIT
-$48.23 M
+$98.28 M+67.08%
30 September 2023
Summary:
As of February 5, 2025, ICPT TTM earnings before interest & taxes is -$48.23 million, with the most recent change of +$98.28 million (+67.08%) on September 30, 2023. Over the past year, it has increased by +$122.25 million (+71.71%).ICPT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -288.0% | +98.8% | +71.7% |
| 3 y3 years | +49.8% | +97.8% | +82.6% |
| 5 y5 years | +53.6% | +97.9% | +84.2% |
ICPT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1043.6% | -103.6% | +1494.0% |
Intercept Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.21 M(-64.2%) | -$48.23 M(-67.1%) |
| June 2023 | - | -$3.38 M(-88.4%) | -$146.51 M(-7.0%) |
| Mar 2023 | - | -$29.07 M(+99.7%) | -$157.58 M(+1.5%) |
| Dec 2022 | -$153.47 M(+288.0%) | -$14.56 M(-85.4%) | -$155.27 M(-8.9%) |
| Sept 2022 | - | -$99.49 M(+588.2%) | -$170.48 M(+128.9%) |
| June 2022 | - | -$14.46 M(-46.0%) | -$74.47 M(+1.4%) |
| Mar 2022 | - | -$26.76 M(-10.1%) | -$73.44 M(-1.7%) |
| Dec 2021 | -$39.55 M(-82.8%) | -$29.77 M(+755.5%) | -$74.68 M(-11.1%) |
| Sept 2021 | - | -$3.48 M(-74.1%) | -$83.98 M(-38.0%) |
| June 2021 | - | -$13.43 M(-52.0%) | -$135.52 M(-22.1%) |
| Mar 2021 | - | -$28.00 M(-28.3%) | -$174.07 M(-23.4%) |
| Dec 2020 | -$229.37 M(-25.0%) | -$39.07 M(-29.0%) | -$227.27 M(-17.9%) |
| Sept 2020 | - | -$55.02 M(+5.9%) | -$276.86 M(-6.1%) |
| June 2020 | - | -$51.98 M(-36.0%) | -$294.88 M(-3.1%) |
| Mar 2020 | - | -$81.21 M(-8.4%) | -$304.44 M(-0.4%) |
| Dec 2019 | -$305.67 M(+9.7%) | -$88.66 M(+21.4%) | -$305.67 M(+2.8%) |
| Sept 2019 | - | -$73.04 M(+18.7%) | -$297.26 M(+5.8%) |
| June 2019 | - | -$61.54 M(-25.3%) | -$281.00 M(-2.1%) |
| Mar 2019 | - | -$82.43 M(+2.7%) | -$287.07 M(+3.0%) |
| Dec 2018 | -$278.72 M(-15.8%) | -$80.25 M(+41.3%) | -$278.72 M(-7.8%) |
| Sept 2018 | - | -$56.78 M(-16.0%) | -$302.31 M(-2.7%) |
| June 2018 | - | -$67.60 M(-8.7%) | -$310.77 M(-3.6%) |
| Mar 2018 | - | -$74.08 M(-28.7%) | -$322.45 M(-2.6%) |
| Dec 2017 | -$331.10 M | -$103.84 M(+59.2%) | -$331.10 M(-2.7%) |
| Sept 2017 | - | -$65.25 M(-17.7%) | -$340.17 M(-4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$79.28 M(-4.2%) | -$356.67 M(+0.6%) |
| Mar 2017 | - | -$82.72 M(-26.7%) | -$354.68 M(-11.0%) |
| Dec 2016 | -$398.63 M(+76.1%) | -$112.91 M(+38.1%) | -$398.63 M(+6.6%) |
| Sept 2016 | - | -$81.75 M(+5.8%) | -$373.98 M(+9.0%) |
| June 2016 | - | -$77.30 M(-39.0%) | -$343.12 M(+9.0%) |
| Mar 2016 | - | -$126.67 M(+43.5%) | -$314.65 M(+38.2%) |
| Dec 2015 | -$226.43 M(-20.1%) | -$88.25 M(+73.4%) | -$227.63 M(-33.9%) |
| Sept 2015 | - | -$50.90 M(+4.2%) | -$344.56 M(+4.5%) |
| June 2015 | - | -$48.82 M(+23.1%) | -$329.74 M(+33.3%) |
| Mar 2015 | - | -$39.66 M(-80.7%) | -$247.45 M(+8.9%) |
| Dec 2014 | -$283.23 M(+617.9%) | -$205.19 M(+468.8%) | -$227.33 M(+530.6%) |
| Sept 2014 | - | -$36.07 M(-207.8%) | -$36.05 M(+225.4%) |
| June 2014 | - | $33.47 M(-271.3%) | -$11.08 M(-78.8%) |
| Mar 2014 | - | -$19.54 M(+40.5%) | -$52.17 M(+32.2%) |
| Dec 2013 | -$39.45 M(+108.6%) | -$13.91 M(+25.3%) | -$39.45 M(+22.9%) |
| Sept 2013 | - | -$11.10 M(+45.7%) | -$32.11 M(+29.5%) |
| June 2013 | - | -$7.62 M(+11.6%) | -$24.79 M(+10.8%) |
| Mar 2013 | - | -$6.82 M(+4.0%) | -$22.38 M(+18.3%) |
| Dec 2012 | -$18.91 M(+36.8%) | -$6.56 M(+73.4%) | -$18.91 M(+12.7%) |
| Sept 2012 | - | -$3.79 M(-27.2%) | -$16.79 M(+4.7%) |
| June 2012 | - | -$5.20 M(+54.9%) | -$16.03 M(+48.1%) |
| Mar 2012 | - | -$3.36 M(-24.3%) | -$10.83 M(+45.0%) |
| Dec 2011 | -$13.83 M(-12.8%) | -$4.44 M(+46.7%) | -$7.47 M(+146.7%) |
| Sept 2011 | - | -$3.03 M | -$3.03 M |
| Dec 2010 | -$15.86 M | - | - |
FAQ
- What is Intercept Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual EBIT year-on-year change?
- What is Intercept Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly EBIT year-on-year change?
- What is Intercept Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM EBIT year-on-year change?
What is Intercept Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ICPT is -$153.47 M
What is the all time high annual EBIT for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual earnings before interest & taxes is -$13.42 M
What is Intercept Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ICPT annual earnings before interest & taxes has changed by -$113.92 M (-288.04%)
What is Intercept Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ICPT is -$1.21 M
What is the all time high quarterly EBIT for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly earnings before interest & taxes is $33.47 M
What is Intercept Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ICPT quarterly earnings before interest & taxes has changed by +$98.28 M (+98.78%)
What is Intercept Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ICPT is -$48.23 M
What is the all time high TTM EBIT for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM earnings before interest & taxes is -$3.03 M
What is Intercept Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ICPT TTM earnings before interest & taxes has changed by +$122.25 M (+71.71%)